Literature DB >> 25424989

Phenotypes of AKT3 deletion: a case report and literature review.

Dayu Gai1, Eric Haan, Matthew Scholar, Jillian Nicholl, Sui Yu.   

Abstract

AKT3 (v-akt murine thymoma viral oncogene homolog 3) is located at chromosome 1q44 and encodes a 479 amino acid protein, a member of the protein kinase B (PKB) family. This gene is frequently involved in 1q44 deletion syndrome in patients with microcephaly, intellectual disability, and dysmorphic features. Phenotype and genotype studies of patients with 1q44 deletion syndrome have suggested that deletion of the AKT3 gene is responsible for the microcephaly in these patients. However, the phenotype of pure AKT3 deletion has not been studied. We report on a 1q44 deletion involving only AKT3 in a boy and his father. The boy has microcephaly, hypotonia, feeding difficulties, developmental delay, and minor dysmorphic features. His father does not have microcephaly and is of normal intelligence. We also analyzed the available information on the phenotypes of 13 individuals carrying a pure AKT3 gene deletion identified through literature review and database search. To our knowledge, this is the first report of a paternally inherited pure AKT3 deletion with full clinical description. This is also the first report to suggest that (1) AKT3 deletion is associated with microcephaly and intellectual disability with incomplete penetrance; (2) a pure AKT3 deletion is likely to be inherited in contrast to the larger 1q44 deletions, which are mostly de novo and (3) there seems to be no consistent or characteristic dysmorphism associated with pure AKT3 deletion.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  1q43-44 deletion; AKT3 deletion; array CGH; developmental delay; microcephaly

Mesh:

Substances:

Year:  2014        PMID: 25424989     DOI: 10.1002/ajmg.a.36710

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing.

Authors:  Anthony M Musolf; Winson S C Ho; Kyle A Long; Zhengping Zhuang; Davis P Argersinger; Haiming Sun; Bilal A Moiz; Claire L Simpson; Elena G Mendelevich; Enver I Bogdanov; Joan E Bailey-Wilson; John D Heiss
Journal:  Eur J Hum Genet       Date:  2019-06-21       Impact factor: 4.246

2.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

3.  Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1.

Authors:  He Wang; Mengjia Liu; Zhuoyang Ye; Cuihua Zhou; Huiru Bi; Long Wang; Chen Zhang; Hui Fu; Ying Shen; Jian-Jun Yang; Yimin Hu; Guiquan Chen
Journal:  J Neurosci       Date:  2021-08-12       Impact factor: 6.167

Review 4.  Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.

Authors:  Filomena Pirozzi; Benson Lee; Nicole Horsley; Deepika D Burkardt; William B Dobyns; John M Graham; Maria L Dentici; Claudia Cesario; Jens Schallner; Joseph Porrmann; Nataliya Di Donato; Pedro A Sanchez-Lara; Ghayda M Mirzaa
Journal:  Am J Med Genet A       Date:  2021-06-04       Impact factor: 2.802

5.  AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity.

Authors:  Josien Levenga; Helen Wong; Ryan A Milstead; Bailey N Keller; Lauren E LaPlante; Charles A Hoeffer
Journal:  Elife       Date:  2017-11-27       Impact factor: 8.140

6.  Epigenetic changes in blood leukocytes following an omega-3 fatty acid supplementation.

Authors:  Bénédicte L Tremblay; Frédéric Guénard; Iwona Rudkowska; Simone Lemieux; Patrick Couture; Marie-Claude Vohl
Journal:  Clin Epigenetics       Date:  2017-04-26       Impact factor: 6.551

7.  Opposite chromosome constitutions due to a familial translocation t(1;21)(q43;q22) in 2 cousins with development delay and congenital anomalies: A case report.

Authors:  Beata Aleksiūnienė; Rugilė Matulevičiūtė; Aušra Matulevičienė; Birutė Burnytė; Natalija Krasovskaja; Laima Ambrozaitytė; Violeta Mikštienė; Vaidas Dirsė; Algirdas Utkus; Vaidutis Kučinskas
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  PKBγ/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.

Authors:  Kristy R Howell; Kirsten Floyd; Amanda J Law
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

9.  Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU.

Authors:  Christel Depienne; Caroline Nava; Boris Keren; Solveig Heide; Agnès Rastetter; Sandrine Passemard; Sandra Chantot-Bastaraud; Marie-Laure Moutard; Pankaj B Agrawal; Grace VanNoy; Joan M Stoler; David J Amor; Thierry Billette de Villemeur; Diane Doummar; Caroline Alby; Valérie Cormier-Daire; Catherine Garel; Pauline Marzin; Sophie Scheidecker; Anne de Saint-Martin; Edouard Hirsch; Christian Korff; Armand Bottani; Laurence Faivre; Alain Verloes; Christine Orzechowski; Lydie Burglen; Bruno Leheup; Joelle Roume; Joris Andrieux; Frenny Sheth; Chaitanya Datar; Michael J Parker; Laurent Pasquier; Sylvie Odent; Sophie Naudion; Marie-Ange Delrue; Cédric Le Caignec; Marie Vincent; Bertrand Isidor; Florence Renaldo; Fiona Stewart; Annick Toutain; Udo Koehler; Birgit Häckl; Celina von Stülpnagel; Gerhard Kluger; Rikke S Møller; Deb Pal; Tord Jonson; Maria Soller; Nienke E Verbeek; Mieke M van Haelst; Carolien de Kovel; Bobby Koeleman; Glen Monroe; Gijs van Haaften; Tania Attié-Bitach; Lucile Boutaud; Delphine Héron; Cyril Mignot
Journal:  Hum Genet       Date:  2017-03-10       Impact factor: 4.132

10.  The tumor suppressor role of microRNA-338-3p in renal cell carcinoma.

Authors:  Yidong Huang; Yang Wu; Li Zeng; Wei Shan; Lugang Huang
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.